Dr Franceschi and colleagues from France conducted a literature search on the seroprevalence of Hepatitis B surface antigen and antibodies against Hepatitis C virus.
The research team assessed 27,881 hepatocellular carcinomas cases from 90 studies.
The team found a predominance of Hepatitis B surface antigen in hepatocellular carcinomas from most Asian, African and Latin American countries.
|Anti-Hep C virus was found more often than Hep B antigens in the USA|
|British Journal of Cancer|
The researchers identified that the anti-Hepatitis C virus predominated in Japan, Pakistan, Mongolia and Egypt.
Anti-Hepatitis C virus was found more often than Hepatitis B antigens in Europe and the United States.
Dr Franceschi's team concludes, “We combined information published worldwide on the seroprevalence of Hepatitis B surface antigen and antibodies against Hepatitis C virus.”
“The results highlighted the variation in the relative importance of Hepatitis B and Hepatitis C viruses in hepatocellular carcinoma.”